Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 A Molecule’s Journey: Break Down Roadblocks to Commercial Manufacturing Success | Contract Pharma

What are you searching for?

Sign in
Sponsored Content

A Molecule’s Journey: Break Down Roadblocks to Commercial Manufacturing Success

In this guidebook, experts share key considerations for biopharmaceutical companies as they advance their antibody drug to commercial manufacturing.

Released By MilliporeSigma

Selection and implementation of a commercial manufacturing strategy is among the most critical decisions a biopharmaceutical company will make. Once the decision to outsource commercial production is made, it is essential to select the right partner. An experienced CDMO will be able to help you address important considerations when it comes to identifying the best approach for your commercial manufacturing. The right strategy must align with your organizational objectives and be cost-effective, deliver the necessary quantity of drug substance, reduce risk and meet regulatory expectations.

In this guidebook, our experts share key considerations for biopharmaceutical companies as they advance their antibody drug to commercial manufacturing and navigate complexities associated with business planning, process scale-up, optimization and validation, technology considerations and regulatory compliance.

Request more information from MilliporeSigma

Request more information from MilliporeSigma

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics